Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome.… Read more
Medicus Pharma Ltd. Warrant (MDCXW) - Net Assets
Latest net assets as of September 2025: $-804.89K USD
Based on the latest financial reports, Medicus Pharma Ltd. Warrant (MDCXW) has net assets worth $-804.89K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.98 Million) and total liabilities ($10.78 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-804.89K |
| % of Total Assets | -8.07% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Medicus Pharma Ltd. Warrant - Net Assets Trend (2021–2024)
This chart illustrates how Medicus Pharma Ltd. Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medicus Pharma Ltd. Warrant (2021–2024)
The table below shows the annual net assets of Medicus Pharma Ltd. Warrant from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.13 Million | +181.87% |
| 2023-12-31 | $1.11 Million | +109.11% |
| 2022-12-31 | $-12.20 Million | -16.11% |
| 2021-12-31 | $-10.51 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medicus Pharma Ltd. Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1818652200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $30.50 Million | 973.56% |
| Other Components | $1.52 Million | 48.50% |
| Total Equity | $3.13 Million | 100.00% |
Medicus Pharma Ltd. Warrant Competitors by Market Cap
The table below lists competitors of Medicus Pharma Ltd. Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TPBI PCL
BK:TPBI
|
$11.07 Million |
|
Pluri Inc.
NASDAQ:PLUR
|
$11.07 Million |
|
MacKenzie Realty Capital, Inc. Common Stock
OTCQX:MKZR
|
$11.08 Million |
|
Transtouch Technology
TWO:3623
|
$11.08 Million |
|
Dgenx Co. Ltd
KQ:113810
|
$11.06 Million |
|
AztechWB Co. Ltd
KQ:032080
|
$11.06 Million |
|
MicroBase Technology Corp.
TWO:3184
|
$11.06 Million |
|
Skkynet Cloud Systems Inc
OTCQB:SKKY
|
$11.05 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medicus Pharma Ltd. Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,111,448 to 3,132,839, a change of 2,021,391 (181.9%).
- Net loss of 11,155,516 reduced equity.
- New share issuances of 7,519,716 increased equity.
- Other factors increased equity by 5,657,191.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.16 Million | -356.08% |
| Share Issuances | $7.52 Million | +240.03% |
| Other Changes | $5.66 Million | +180.58% |
| Total Change | $- | 181.87% |
Book Value vs Market Value Analysis
This analysis compares Medicus Pharma Ltd. Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.56x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $-5.57 | $0.68 | x |
| 2022-12-31 | $-2.45 | $0.68 | x |
| 2023-12-31 | $0.14 | $0.68 | x |
| 2024-12-31 | $0.27 | $0.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medicus Pharma Ltd. Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -356.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.80x
- Recent ROE (-356.08%) is below the historical average (-208.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.00 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-472.58K |
| 2023 | -478.18% | 0.00% | 0.00x | 1.70x | $-5.43 Million |
| 2024 | -356.08% | 0.00% | 0.00x | 1.80x | $-11.47 Million |
Industry Comparison
This section compares Medicus Pharma Ltd. Warrant's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medicus Pharma Ltd. Warrant (MDCXW) | $-804.89K | 0.00% | N/A | $11.07 Million |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |